The
sphingosine kinase-1/
sphingosine 1-phosphate (SphK1/S1P) pathway has been associated with
cancer promotion and progression and resistance to treatments in a number of
cancers, including prostate
adenocarcinoma. Here we provide the first evidence that dietary agents, namely,
epigallocatechin gallate (EGCg, IC(50)≈75 μM),
resveratrol (IC(50)≈40 μM), or a mixture of
polyphenols from
green tea [
polyphenon E (PPE), IC(50)≈70 μM] or grapevine extract (
vineatrol, IC(50)≈30 μM), impede
prostate cancer cell growth in vitro and in vivo by inhibiting the SphK1/S1P pathway. We establish that SphK1 is a downstream effector of the ERK/
phospholipase D (
PLD) pathway, which is inhibited by
green tea and wine
polyphenols. Enforced expression of SphK1 impaired the ability of
green tea and wine
polyphenols, as well as pharmacological inhibitors of
PLD and ERK activities, to induce apoptosis in PC-3 and C4-2B cells. The therapeutic efficacy of these
polyphenols on
tumor growth and the SphK1/S1P pathway were confirmed in animals using a heterotopic PC-3
tumor in place model. PC-3/SphK1 cells implanted in animals developed larger
tumors and resistance to treatment with
polyphenols. Furthermore, using an orthotopic PC-3/GFP model, the chemopreventive effect of an EGCg or PPE diet was associated with SphK1 inhibition, a decrease in primary
tumor volume, and occurrence and number of
metastases. These results provide the first demonstration that the prosurvival, antiapoptotic SphK1/S1P pathway represents a target of dietary
green tea and wine
polyphenols in
cancer.